Literature DB >> 3111162

Contribution of histiocytic cells to sarcomatous development of the gliosarcoma. An immunohistochemical study.

N Kochi, H Budka.   

Abstract

The expression of glial fibrillary acidic protein, fibronectin (FN), factor VIII-related antigen (FVIII/RAG), and of three monohistiocytic markers, lysozyme, alpha-1-antitrypsin and alpha-1-antichymotrypsin was examined in five gliosarcomas (GS) by peroxidase-antiperoxidase immunostaining of formalin-fixed and paraffin-embedded specimens, and compared with vascular changes in 16 glioblastomas (GB). In contrast to GB, endothelial proliferations of GS were sheathed by sarcomatous tissue (perivascular sarcoma), which was contiguous with fibrosarcomatous areas. Cells with conspicuous intracytoplasmic FN content (FN+ cells) were seen in the vascular stroma of GB and dominated in the sarcomatous parts of GS. Most FN+ cells of GS were of varying size and shape and clearly neoplastic. Monohistiocytic markers were demonstrable in small infiltrating mononuclear cells as well as in many sarcomatous cells including FN+ cells. FVIII/RAG was restricted to lumen-lining endothelium and was not found in sarcomatous cells. These results suggest that a major part of sarcoma in GS is less likely to develop from proliferated endothelial cells than from histiocytic cells in the perivascular spaces of GB. By FN mediation, histiocytic cells might also guide and promote sarcomatous proliferations of other mesenchymal cells, leading to fibrosarcomatous development. Prominent monstrous giant cells of one GS seemed to be degenerating glioma cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3111162     DOI: 10.1007/bf00693777

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  34 in total

1.  The endothelial hyperplasia of the cerebral blood vessels with brain tumors, and its sarcomatous transformation.

Authors:  I FEIGIN; L B ALLEN; L LIPKIN; S W GROSS
Journal:  Cancer       Date:  1958 Mar-Apr       Impact factor: 6.860

2.  Contribution of immunohistochemistry to diagnostic problems of human cerebral tumors.

Authors:  L F Eng; L J Rubinstein
Journal:  J Histochem Cytochem       Date:  1978-07       Impact factor: 2.479

3.  Contiguous glioblastoma multiforme and fibrosarcoma with extracranial metastasis.

Authors:  D R Smith; J M Hardman; K M Earle
Journal:  Cancer       Date:  1969-08       Impact factor: 6.860

4.  Ultrastructure of a composite glioma-sarcoma of the brain.

Authors:  C E Peña; R Felter
Journal:  Acta Neuropathol       Date:  1973       Impact factor: 17.088

5.  Sequential appearance of fibronectin and collagen fibres in experimental arthritis in rabbits.

Authors:  B Hølund; I Clemmensen; M Wanning
Journal:  Histochemistry       Date:  1984

6.  Sequential appearance of fibronectin and collagen in experimental granulation tissue.

Authors:  M Kurkinen; A Vaheri; P J Roberts; S Stenman
Journal:  Lab Invest       Date:  1980-07       Impact factor: 5.662

7.  Clinical and pathological study of 24 cases of gliosarcoma.

Authors:  R A Morantz; I Feigin; J Ransohoff
Journal:  J Neurosurg       Date:  1976-10       Impact factor: 5.115

8.  GFAP, F VIII/RAg, laminin, and fibronectin in gliosarcomas: an immunohistochemical study.

Authors:  D Schiffer; M T Giordana; A Mauro; A Migheli
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

9.  The distribution of fibronectin in lymph nodes infiltrated by Hodgkin's disease. An immunoperoxidase study on paraffin sections.

Authors:  P Möller; H Achtsätter; M Butzengeiger; B Schüle
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

10.  Immunohistochemical detection of factor VIII/von Willebrand factor in hyperplastic endothelial cells in glioblastoma multiforme and mixed glioma-sarcoma.

Authors:  R D McComb; T R Jones; S V Pizzo; D D Bigner
Journal:  J Neuropathol Exp Neurol       Date:  1982-09       Impact factor: 3.685

View more
  13 in total

1.  Sarcomatous proliferation of the vasculature in a subependymoma: a follow-up study of sarcomatous dedifferentiation.

Authors:  D N Louis; E T Hedley-Whyte; R L Martuza
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Gliofibroma: immunohistochemical analysis.

Authors:  R Schober; C Bayindir; A Canbolat; H Urich; W Wechsler
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Multi-focal gliosarcoma: a case report and review of the literature.

Authors:  E E Pakos; A C Goussia; V P Zina; E J Pitouli; P G Tsekeris
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

4.  Immunohistochemical investigation of collagen subtypes in human glioblastomas.

Authors:  W Paulus; W Roggendorf; D Schuppan
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

5.  Histogenesis of sarcomatous component of the gliosarcoma: an ultrastructural study.

Authors:  K L Ho
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Genetic profile of gliosarcomas.

Authors:  R M Reis; D Könü-Lebleblicioglu; J M Lopes; P Kleihues; H Ohgaki
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

7.  Distribution of collagen type IV in brain tumors: an immunohistochemical study.

Authors:  K Ogawa; M Oguchi; Y Nakashima; H Yamabe
Journal:  J Neurooncol       Date:  1989-11       Impact factor: 4.130

8.  Sarcoma arising as a distinct nodule within glioblastoma: a morphological and molecular perspective on gliosarcoma.

Authors:  Cynthia Jimenez; Martin Powers; Andrew T Parsa; Christine Glastonbury; Jill M Hagenkord; Tarik Tihan
Journal:  J Neurooncol       Date:  2011-05-01       Impact factor: 4.130

Review 9.  Gliofibromas (including malignant forms), and gliosarcomas: a comparative study and review of the literature.

Authors:  M Cerda-Nicolas; J J Kepes
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  Sarcomatous proliferation of the vasculature in a subependymoma.

Authors:  D N Louis; E T Hedley-Whyte; R L Martuza
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.